Skip to menu Skip to content Skip to footer
Professor Mark Smithers
Professor

Mark Smithers

Email: 

Overview

Background

Emeritus Professor Mark Smithers is a surgical oncologist who specialises in surgery for oesophago-gastric diseases, melanoma, advanced skin cancer and soft tissue sarcoma. He was the Director of the Upper GI and Soft Tissue Unit at the Princess Alexandra Hospital, in Brisbane, Australia from 1998 - 2023. Commencing his academic career with the University of Queensland in 1987, he progressed to be the Mayne Chair in Surgery and head of the Academy of Surgery. He is the second University of Queensland Medical graduate to be appointed to this role. His research has been focussed on the development and assessment of outcomes from minimally invasive upper GI surgery, and trials assessing the role of perioperative multidisciplinary therapy for esophageal and gastric cancer. As well he has led, or been involved with, clinical trials from phase I to III, for all stages of melanoma through his role as the Chair of the Queensland Melanoma Project. More recently he has been involved with the assessment of access to, and outcomes from, surgery for cancer in Queensland, Australia.

He has overseen the administration and development of the surgery curriculum, and the teaching, in the Academy of Surgery, in the UQ Faculty of Medicine. He was on a number of committees relevant to the implementation of the UQ MD design course. He has held various leadership and committee roles with the Royal Australasian College of Surgeons, as well as leadership roles, including the Presidency, in the Australian and New Zealand Oesophago Gastric Surgeons Association. He has also been on the committees of international organisations related to oesophageal and gastric surgery. He has published 250 articles, eight book chapters, and has been on the editorial board of a number of surgical journals.

He has been recognised for his clinical and academic roles by the award of Member of the Order of Australia (AM). The citation reads, "for service to medicine in the fields of gastro-intestinal and melanoma surgery, to medical education and to professional organisations". The Royal Australasian College of Surgeons awarded him the Sir Hugh Devine medal, for services to surgery and the community. This is the College’s highest honour. Internationally, he has been awarded an honorary fellowship of the Royal College of Surgeons of Edinburgh and recently, in the United States, he was elected as an Honarary Fellow of the American Surgical Association.

Availability

Professor Mark Smithers is:
Not available for supervision
Media expert

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Honorary Fellow, American Surgical Association, American Surgical Association
  • Fellow, Royal Australasian College of Surgeons, Royal Australasian College of Surgeons
  • Fellow, Royal College of Surgeons of Edinburgh, Royal College of Surgeons of Edinburgh
  • Fellow, Royal College of Surgeons of England, Royal College of Surgeons of England

Research interests

  • Cutaneous Melanoma

    epidemiology, public health issues and management of all stages

  • Management of Oesophageal and Gastric Cancer

    Investigation and management of benign and malignant diseases of the oesophagus and the stomach.

Works

Search Professor Mark Smithers’s works on UQ eSpace

410 works between 1983 and 2025

301 - 320 of 410 works

2006

Conference Publication

Isolated limb infusion (ILI) for malignant melanoma: Predictors of response and outcome

Barbour, A.P., Beller, E. and Smithers, B.M. (2006). Isolated limb infusion (ILI) for malignant melanoma: Predictors of response and outcome. The 59th Annual Cancer Symposium of the Society of Surgical Oncology, San Diego, CA, 23-26 March 2006. Hagerstown, U.S.A.: Springer.

Isolated limb infusion (ILI) for malignant melanoma: Predictors of response and outcome

2006

Journal Article

Minimally invasive esophagectomy

Leibman, S., Smithers, B. M., Gotley, D. C., Martin, I. and Thomas, J. (2006). Minimally invasive esophagectomy. Surgical Endoscopy And Other Interventional Techniques, 20 (3), 428-433. doi: 10.1007/s00464-005-0388-y

Minimally invasive esophagectomy

2006

Journal Article

Urban-rural differences in survival from cutaneous melanoma in Queensland

Coory, Michael, Smithers, Mark, Aitken, Joanne, Baade, Peter and Ring, Ian (2006). Urban-rural differences in survival from cutaneous melanoma in Queensland. Australian & New Zealand Journal of Public Health, 30 (1), 71-74. doi: 10.1111/j.1467-842X.2006.tb00089.x

Urban-rural differences in survival from cutaneous melanoma in Queensland

2006

Conference Publication

Patterns and predictors of initial recurrence following resection for adenocarcinoma of the oesophagus and gastro-oesophageal junction

Barbour, A. P., Smithers, B. M., Gotley, D. C., Thomas, J., Burmeister, B. H. and Walpole, E. T. (2006). Patterns and predictors of initial recurrence following resection for adenocarcinoma of the oesophagus and gastro-oesophageal junction. The RACS Annual Scientific Congress, Sydney Convention & Exhibition Centre, Darling Harbour, Sydney, 15-19 May 2006. Australia: Blackwell Publishing Asia.

Patterns and predictors of initial recurrence following resection for adenocarcinoma of the oesophagus and gastro-oesophageal junction

2006

Conference Publication

Isolated limb infusion (ILT) for malignant melanoma: Predictors of response and outcome

Barbour, AP, Beller, E and Smithers, BM (2006). Isolated limb infusion (ILT) for malignant melanoma: Predictors of response and outcome. 59th Annual Cancer Symposium of the Society-of-Surgical-Oncology, San Diego CA, MAR 23-26, 2006. NEW YORK: SPRINGER.

Isolated limb infusion (ILT) for malignant melanoma: Predictors of response and outcome

2006

Journal Article

Radiotherapy for metastatic melanoma presenting in pregnancy

Daly, T., Burmeister, B, Smithers, B M, Doody, J. and Kane, A. (2006). Radiotherapy for metastatic melanoma presenting in pregnancy. Australasian Radiology, 50 (6), 598-603. doi: 10.1111/j.1440-1673.2006.01641.x

Radiotherapy for metastatic melanoma presenting in pregnancy

2005

Journal Article

Acute and long-term effect of alpha-glucosidase inhibitor on dumping syndrome in a patient after a vagotomy and pyloric surgery *

Smith, Louise, Smithers, Mark, Prins, Johannes and O'Moore-Sullivan, Trisha (2005). Acute and long-term effect of alpha-glucosidase inhibitor on dumping syndrome in a patient after a vagotomy and pyloric surgery *. The Australian and New Zealand Journal of Surgery, 75 (12), 1124-1126. doi: 10.1111/j.1445-2197.2005.03628.x

Acute and long-term effect of alpha-glucosidase inhibitor on dumping syndrome in a patient after a vagotomy and pyloric surgery *

2005

Journal Article

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors’ reply

Burmeister, Bryan H. and Smithers, B. Mark (2005). Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors’ reply. Lancet Oncology, 6 (11), 825-825. doi: 10.1016/S1470-2045(05)70402-2

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer – Authors’ reply

2005

Journal Article

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus

Smith, Kylie J., O'Brien, Suzanne M., Smithers, B. Mark, Gotley, David C., Webb, Penelope M., Green, Adèle C. and Whiteman, David C. (2005). Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiology Biomarkers & Prevention, 14 (11), 2481-2486. doi: 10.1158/1055-9965.EPI-05-0370

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus

2005

Journal Article

Neoadjuvant chemoadiotherapy in resectable oesophageal cancer - Authors' reply

Burmeister, Bryan H. and Smithers, B.Mark (2005). Neoadjuvant chemoadiotherapy in resectable oesophageal cancer - Authors' reply. Lancet Oncology, 6 (11), 825-826. doi: 10.1016/S1470-2045(05)70402-2

Neoadjuvant chemoadiotherapy in resectable oesophageal cancer - Authors' reply

2005

Journal Article

Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery

Byrne, J. P., Smithers, B. M., Nathanson, L. K., Martin, I., Ong, H. S. and Gotley, D. C. (2005). Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery. British Journal of Surgery, 92 (8), 996-1001. doi: 10.1002/bjs.4914

Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery

2005

Conference Publication

Preoperative adjuvant chemoradiation therapy for localised oesophageal cancer – study 9401 and the aftermath

Burmeister, B. H. and Smithers, B. M. (2005). Preoperative adjuvant chemoradiation therapy for localised oesophageal cancer – study 9401 and the aftermath. Clinical Oncological Society of Australia 32nd Annual Scientific Meeting 2005, Brisbane, Australia, 16-18 November, 2005. Blackwell Publishing Asia. doi: 10.1111/j.1743-7563.2005.00027.x

Preoperative adjuvant chemoradiation therapy for localised oesophageal cancer – study 9401 and the aftermath

2005

Journal Article

Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin

Burmeister, B., Walpole, E. T., Burmeister, E., Thomas, J., Thomson, D. B., Harvey, J., Smithers, B. M. and Gotley, D. C. (2005). Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin. International Journal of Clinical Oncology, 10 (4), 256-261. doi: 10.1007/s10147-005-0506-9

Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin

2005

Journal Article

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

Burmeister, B. H., Smithers, B. M., Gebski, V., Fitzgerald, L., Simes, R. J., Devitt, P., Ackland, S., Gotley, D. C., Joseph, D., Millar, J., North, J., Walpole, E. T. and Denham, J. W. (2005). Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncology, 6 (9), 659-668. doi: 10.1016/S1470-2045(05)70288-6

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

2005

Journal Article

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer

Pramesh, C. S., Mistry, Rajesh C., Laskar, Sarbani G., Burmeister, Bryan H. and Smithers, B. Mark (2005). Neoadjuvant chemoradiotherapy in resectable oesophageal cancer. Lancet Oncology, 6 (11), 824-825. doi: 10.1016/S1470-2045(05)70401-0

Neoadjuvant chemoradiotherapy in resectable oesophageal cancer

2005

Conference Publication

A prospective phase II study of postoperative radiation therapy following nodal surgery for malignant melanoma – Trans Tasman Radiation Oncology Group (TROG) study 96.06

Burmeister, B. H., Smithers, B. M., Burmeister, E. A., Baumann, K. C., Davis, S. R., Krawitz, H., Johnson, C. and Spry N. (2005). A prospective phase II study of postoperative radiation therapy following nodal surgery for malignant melanoma – Trans Tasman Radiation Oncology Group (TROG) study 96.06. Clinical Oncological Society of Australia 32nd Annual Scientific Meeting 2005, Brisbane, QLD Australia, 16-18 November 2005. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1743-7563.2005.00027.x

A prospective phase II study of postoperative radiation therapy following nodal surgery for malignant melanoma – Trans Tasman Radiation Oncology Group (TROG) study 96.06

2005

Journal Article

Novel approach to oesophageal resection

Smithers, Mark (2005). Novel approach to oesophageal resection. ANZ Journal of Surgery, 75 (12), 1029-1029. doi: 10.1111/j.1445-2197.2005.03661.x

Novel approach to oesophageal resection

2004

Journal Article

Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia

Harvey, J. A., Bessell, J. R., Beller, E., Thomas, J., Gotley, D. C., Burmeister, B. H., Walpole, E. T., Thomson, D. B., Martin, I., Doyle, L., Burmeister, E. and Smithers, B. M. (2004). Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia. Diseases of The Esophagus, 17 (3), 260-265. doi: 10.1111/j.1442-2050.2004.00420.x

Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia

2004

Journal Article

Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy

Brown, WA, Thomas, J, Gotley, D, Burmeister, BH, Lim, KH, Martin, I, Walpole, ET, Thomson, DB, Harvey, JA and Smithers, BM (2004). Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy. British Journal of Surgery, 91 (2), 199-204. doi: 10.1002/bjs.4411

Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy

2004

Book Chapter

Primary melanomas of the gastrointestinal tract

Smithers, B. M. (2004). Primary melanomas of the gastrointestinal tract. Textbook of Melanoma. (pp. 648-662) edited by J. Thompson. London, United Kingdom: Martin Dunitz.

Primary melanomas of the gastrointestinal tract

Supervision

Availability

Professor Mark Smithers is:
Not available for supervision

Supervision history

Current supervision

  • Master Philosophy

    Retroperitoneal sarcoma: Impact of the patterns of care on patient outcomes in Queensland.

    Principal Advisor

    Other advisors: Professor Andrew Barbour

  • Master Philosophy

    Trends in the regional nodal management of cutaneous melanoma.

    Principal Advisor

    Other advisors: Professor Peter Soyer

  • Master Philosophy

    Factors Influencing Anastomotic Complications after Oesophagectomy

    Associate Advisor

  • Doctor Philosophy

    Utilising the Multi-Disciplinary Resources at Tertiary Centres to Improve Outcomes from Pancreatic Cancer

    Associate Advisor

    Other advisors: Dr David Cavallucci

Completed supervision

Media

Enquiries

Contact Professor Mark Smithers directly for media enquiries about:

  • Advanced endoscopic surgery
  • Cancer surgery
  • Endoscopic surgery
  • General surgery
  • Melanoma
  • Surgery - cancer
  • Surgery - oesophageal, gastric cancer
  • Surgery - upper GI
  • Upper GI surgery

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au